IntegraGen is a leader in genome analysis and the development and commercialization of molecular diagnostic tests for oncology.
Genomic Services
miRpredX 31-3p
Investors
Latest news // Archive
-
Press releases
IntegraGen Reports 2017 Annual Results: Continued Strength in Clinical Genomic Services and Improved Net Income
-
Press releases
IntegraGen Presents Data from Liquid Biopsy Studies of Proprietary miRNAs during 2018 European Lung Cancer Conference
-
News
Technical Validation Data for miR-31-3p test Published in Biomarker Insights